Psychemedics Corporation (PMD)
NASDAQ: PMD · Real-Time Price · USD
2.332
+0.002 (0.07%)
Nov 21, 2024, 11:46 AM EST - Market open

Psychemedics Revenue

Psychemedics had revenue of $5.18M in the quarter ending September 30, 2024, a decrease of -9.27%. This brings the company's revenue in the last twelve months to $20.26M, down -11.16% year-over-year. In the year 2023, Psychemedics had annual revenue of $22.10M, down -12.45%.

Revenue (ttm)
$20.26M
Revenue Growth
-11.16%
P/S Ratio
0.67
Revenue / Employee
$174,638
Employees
116
Market Cap
13.74M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202322.10M-3.14M-12.45%
Dec 31, 202225.24M331.00K1.33%
Dec 31, 202124.91M3.55M16.62%
Dec 31, 202021.36M-16.32M-43.31%
Dec 31, 201937.68M-5.00M-11.71%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cumberland Pharmaceuticals 36.79M
STRATA Skin Sciences 32.68M
Vivos Therapeutics 14.58M
Can-Fite BioPharma 667.00K
Traws Pharma 226.00K
Revenue Rankings